# Principal investigator
> 2019.10.18 [ğŸš€](../index/index.md) [despace](index.md) â†’ **[](.md)**

[TOC]

---

> <small>**Principal investigator (PI)** â€” Ğ°Ğ½Ğ³Ğ»Ğ¾ÑĞ·Ñ‹Ñ‡Ğ½Ñ‹Ğ¹ Ñ‚ĞµÑ€Ğ¼Ğ¸Ğ½, Ğ½Ğµ Ğ¸Ğ¼ĞµÑÑ‰Ğ¸Ğ¹ Ğ°Ğ½Ğ°Ğ»Ğ¾Ğ³Ğ° Ğ² Ñ€ÑƒÑÑĞºĞ¾Ğ¼ ÑĞ·Ñ‹ĞºĞµ. **ĞÑ‚Ğ²ĞµÑ‚ÑÑ‚Ğ²ĞµĞ½Ğ½Ñ‹Ğ¹ Ğ¸ÑÑĞ»ĞµĞ´Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ÑŒ** â€” Ğ´Ğ¾ÑĞ»Ğ¾Ğ²Ğ½Ñ‹Ğ¹ Ğ¿ĞµÑ€ĞµĞ²Ğ¾Ğ´ Ñ Ğ°Ğ½Ğ³Ğ»Ğ¸Ğ¹ÑĞºĞ¾Ğ³Ğ¾ Ğ½Ğ° Ñ€ÑƒÑÑĞºĞ¸Ğ¹.</small>

In Canada & the United States, the term **principal investigator (PI)** refers to the holder of an independent grant & the lead researcher for the grant project, usually in the sciences, such as a laboratory study or a clinical trial. The phrase is also often used as a synonym for Â«head of the laboratoryÂ» or Â«research group leaderÂ». While the expression is common in the sciences, it is used widely for the person or persons who make final decisions & supervise funding & expenditures on a given research project.

A coâ€‘investigator (Coâ€‘I) assists the principal investigator in the management & leadership of the research project. There may be a number of coâ€‘investigators supporting a PI.



## Federal funding
In the context of US federal funding from agencies such as the National Institutes of Health (NIH) or the National Science Foundation (NSF), the PI is the person who takes direct responsibility for completion of a funded project, directing the research & reporting directly to the funding agency. For small projects (which might involve 1â€¯â€‘â€¯5â€¯people) the PI is typically the person who conceived of the investigation, but for larger projects the PI may be selected by a team to obtain the best strategic advantage for the project.

In the context of a clinical trial a PI may be an academic working with grants from NIH or other funding agencies, or may be effectively a contractor for a pharmaceutical company working on testing the safety & efficacy of new medicines.

There were 20â€¯458â€¯PIs on NIH R01 grants in US biomedical research in 2000. In 2013, this number has grown to 21â€¯511. At the same time the success rate for an applicant to receive an R01 grant has gone down from 32â€¯% in 2000 to 17â€¯% in 2013.



<p style="page-break-after:always">â€¯</p>

## Docs & links (TRANSLATEME ALREADY)
|Navigation|
|:--|
|**[FAQ](faq.md)**ã€**[SCS](scs.md)**Â·ĞšĞš, **[SCâ€¯(OE+SGM)](sc.md)**Â·ĞšĞã€‘**[CON](contact.md)Â·[Pers](person.md)**Â·ĞšĞ¾Ğ½Ñ‚Ğ°ĞºÑ‚, **[Ctrl](control.md)**Â·Ğ£Ğ¿Ñ€., **[Doc](doc.md)**Â·Ğ”Ğ¾Ğº., **[EF](ef.md)**Â·Ğ’Ğ’Ğ¤, **[Error](error.md)**Â·ĞÑˆĞ¸Ğ±ĞºĞ¸, **[Event](event.md)**Â·Ğ¡Ğ¾Ğ±Ñ‹Ñ‚Ğ¸Ñ, **[FS](fs.md)**Â·Ğ¢Ğ­Ğ, **[HF&E](hfe.md)**Â·Ğ­Ñ€Ğ³Ğ¾., **[KT](kt.md)**Â·ĞšĞ¢, **[Model](model.md)**Â·ĞœĞ¾Ğ´ĞµĞ»ÑŒ, **[N&B](nnb.md)**Â·Ğ‘ĞĞ, **[Patent](Ğ¿Ğ°Ñ‚ĞµĞ½Ñ‚.md)**Â·ĞŸĞ°Ñ‚., **[Project](project.md)**Â·ĞŸÑ€Ğ¾ĞµĞºÑ‚, **[QM](qm.md)**Â·Ğ‘ĞšĞĞ , **[R&D](rnd.md)**Â·ĞĞ˜ĞĞšĞ , **[SI](si.md)**Â·Ğ¡Ğ˜, **[Test](test.md)**Â·Ğ­Ğ, **[TRL](trl.md)**Â·Ğ£Ğ“Ğ¢, **[Way](way.md)**Â·ĞŸÑƒÑ‚Ğ¸|
|*Sections & pages*|
|**ã€[](.md)ã€‘**<br> <mark>NOCAT</mark>|

   1. Docs: â€¦
   1. Notable interwikies â€” â€¦
   1. <https://en.wikipedia.org/wiki/Principal_investigator>
